PHARMACOECONOMIC ANALYSIS IN FORMULARY DECISIONS - AN INTERNATIONAL PERSPECTIVE

被引：11

作者：

JOHNSON, JA ^{[1
]}

BOOTMAN, JL ^{[1
]}

机构：

[1] UNIV ARIZONA, CTR PHARMACEUT ECON, DEPT PHARM PRACTICE, TUCSON, AZ 85721 USA

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1994年 / 51卷 / 20期

关键词：

D O I：

10.1093/ajhp/51.20.2593

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2593 / 2598

页数：6

共 41 条

[1] REDUCING THE NUMBER OF FORMULARY THEOPHYLLINE PREPARATIONS [J].

ANANDAN, JV .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (04) :511-513

[2] IMPROVING DRUG-THERAPY DECISIONS THROUGH EDUCATIONAL OUTREACH - A RANDOMIZED CONTROLLED TRIAL OF ACADEMICALLY BASED DETAILING [J].

AVORN, J ;

SOUMERAI, SB .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1457-1463

[3]

Bonk R J, 1993, Pharmacoeconomics, V4, P73, DOI 10.2165/00019053-199304020-00001

[4] PHARMACOECONOMIC RESEARCH AND CLINICAL-TRIALS - CONCEPTS AND ISSUES [J].

BOOTMAN, JL ;

LARSON, LN ;

MCGHAN, WF ;

TOWNSEND, RJ .

DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (09) :693-697

[5]

BOOTMAN JL, 1991, PRINCIPLES PHARMACOE

[6] ASSESSMENT OF THE RISK-BENEFIT RATIO FOR ANTIARRHYTHMIC DRUG-USE [J].

CAMPBELL, RWF .

DRUGS, 1988, 36 (05) :616-632

[7]

Chan J, 1991, Can J Hosp Pharm, V44, P161

[8]

Detsky A S, 1993, Pharmacoeconomics, V3, P354, DOI 10.2165/00019053-199303050-00003

[9] A CLINICIAN GUIDE TO COST-EFFECTIVENESS ANALYSIS [J].

DETSKY, AS ;

NAGLIE, IG .

ANNALS OF INTERNAL MEDICINE, 1990, 113 (02) :147-154

[10]

DICKSON M, 1992, CLIN THER, V14, P604

← 1 2 3 4 5 →